tazarotene Cutaneous gel 0.1 %

This pharmaceutical company, established in the Middle East, has been operating for over two decades. Their focus is on manufacturing and distributing branded generics, with a particular emphasis on providing quality medicines to the local region. They boast a significant workforce and an extensive product portfolio, including over 200 products. The company's key therapy areas include cardiovascular, gynecological, and gastrointestinal health. Their production lines include a wide range of dosage forms, such as solids, liquids, and injectables. They have obtained EU and US GMP approvals, demonstrating their commitment to high-quality manufacturing standards. Their products are distributed across various markets, including the Middle East, and they are actively expanding their presence in international markets.